Patent ID: 8921330
Filing Date: 2014-12-30
Classification: A61K,A61P,C12N,Y10T

Abstract:
1. A method of upregulating a function of and/or the expression of a RCAN1 polynucleotide in patient cells or tissues in vitro comprising: contacting said cells or tissues with at least one single stranded antisense oligonucleotide of about 10 to 30 nucleotides in length that targets a 10 to 30 consecutive nucleotide region of a natural antisense oligonucleotide of the RCAN1 polynucleotide selected from SEQ ID NOS: 5 or 6; thereby upregulating the function of and/or the expression of the RCAN1 Gene polynucleotide in patient cells or tissues in vitro.